Group also will update media on world’s largest biotechnology gathering which will be held in San Francisco in June
WHAT: • The Biotechnology Innovation Organization (BIO) will present the most up-to-date bioscience jobs and industry growth numbers and an overview of the industry’s position and recent performance for the Greater San Francisco Bay Area, including the San Jose Metropolitan Areas
• Highlight projected economic impact of forthcoming BIO International Convention
• Discussion of city and state initiatives in support of biotech industry growth
WHO: • Paul Hastings, Chairman and CEO of OncoMed Pharmaceuticals, Chair of BIO’s Board Patient br>Advocacy Committee and Chairman of BIO International Convention Steering Committee
• Sara Radcliffe, President & CEO, California Life Sciences Association (CLSA)
• Todd Rufo, Director of the Office of Economic & Workforce Development, City of San Francisco
• Louis Stewart, Deputy Director of Innovation and Entrepreneurship, Governor's Office of Business & Economic Development (GO-Biz)
WHEN: Wednesday, March 9th, 2016, 3:00 pm
WHERE:
Lobby of Moscone South
747 Howard St, San Francisco, California 94103
About BIO
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.
WHAT: • The Biotechnology Innovation Organization (BIO) will present the most up-to-date bioscience jobs and industry growth numbers and an overview of the industry’s position and recent performance for the Greater San Francisco Bay Area, including the San Jose Metropolitan Areas
• Highlight projected economic impact of forthcoming BIO International Convention
• Discussion of city and state initiatives in support of biotech industry growth
WHO: • Paul Hastings, Chairman and CEO of OncoMed Pharmaceuticals, Chair of BIO’s Board Patient br>Advocacy Committee and Chairman of BIO International Convention Steering Committee
• Sara Radcliffe, President & CEO, California Life Sciences Association (CLSA)
• Todd Rufo, Director of the Office of Economic & Workforce Development, City of San Francisco
• Louis Stewart, Deputy Director of Innovation and Entrepreneurship, Governor's Office of Business & Economic Development (GO-Biz)
WHEN: Wednesday, March 9th, 2016, 3:00 pm
WHERE:
Lobby of Moscone South
747 Howard St, San Francisco, California 94103
About BIO
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.
